Mental Health Issues Linked To Smoking Cessation Medication

In a new report, the FDA has discovered that there could be a link between smoking cessation medications, Chantix and Zyban, and changes in one’s mental health, such as depressive mood swings, hostility and suicidal tendencies. A new labelling is being drawn up for medications such as these, including generic versions of these treatments, in order to warn of the new potential side effects. Those taking these medications who feel a sudden or dramatic change in their mood, such as feeling the need to hurt themselves, should cease taking the drugs immediately and seek advice from their GP as soon as possible.

It’s important for people trying to quit smoking to weigh up the risks from smoking with those from the side effects of the drugs – while smoking is, of course, bad for your health, there may be other ways in which to give up. Smoking is extremely bad for your body, causing a risk of lung cancer, disability and stroke to name just a few ailments. If you’re smoking, no matter how much, it’s crucial that you give up as soon as possible to reduce your risk of such harmful side effects.

The study found that people taking Chantrix or Zyban could be at risk of depressive or suicidal tendencies even after stopping the medication. In many of these cases, it was noted that the nicotine withdrawal symptoms brought with them mental effects such as sleep disturbances, irritability and anxiety. Patients should be aware of these symptoms so that they are prepared for them when they give up cigarettes. You shouldn’t be put off from giving up smoking though – while it does require a lot of determination and willpower, it will decrease your risk of lung cancer and heart disease, among providing other positive effects on your body.